NASDAQ:CYAD
$1.24
(
-1.59%
)
Friday, 3rd Feb 2023
Celyad SA Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.515 | $3.07 | Friday, 3rd Feb 2023 CYAD stock ended at $1.24. This is 1.59% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 4.10% from a day low at $1.22 to a day high of $1.27. |
| 90 days | $0.460 | $3.07 | |
| 52 weeks | $0.460 | $3.63 |
Historical Celyad SA prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $1.22 | $1.27 | $1.22 | $1.24 | 37 798 |
| 2023-02-02 | $1.31 | $1.40 | $1.21 | $1.26 | 65 554 |
| 2023-02-01 | $1.34 | $1.42 | $1.25 | $1.30 | 42 175 |
| 2023-01-31 | $1.40 | $1.49 | $1.32 | $1.35 | 78 929 |
| 2023-01-30 | $1.38 | $1.46 | $1.30 | $1.35 | 111 831 |
| 2023-01-27 | $1.42 | $1.43 | $1.26 | $1.29 | 150 555 |
| 2023-01-26 | $1.66 | $1.72 | $1.49 | $1.57 | 155 343 |
| 2023-01-25 | $1.66 | $1.80 | $1.62 | $1.73 | 138 009 |
| 2023-01-24 | $1.98 | $2.10 | $1.48 | $1.61 | 401 892 |
| 2023-01-23 | $1.95 | $2.25 | $1.86 | $2.07 | 482 362 |
| 2023-01-20 | $2.13 | $2.18 | $1.94 | $1.94 | 784 014 |
| 2023-01-19 | $2.22 | $2.55 | $1.91 | $2.20 | 2 780 724 |
| 2023-01-18 | $2.04 | $3.07 | $1.89 | $2.37 | 20 142 417 |
| 2023-01-17 | $1.30 | $2.50 | $1.13 | $1.90 | 65 344 807 |
| 2023-01-13 | $0.740 | $0.80 | $0.730 | $0.799 | 27 522 |
| 2023-01-12 | $0.703 | $0.750 | $0.660 | $0.660 | 6 914 |
| 2023-01-11 | $0.685 | $0.685 | $0.685 | $0.685 | 311 |
| 2023-01-10 | $0.700 | $0.700 | $0.660 | $0.685 | 9 700 |
| 2023-01-09 | $0.760 | $0.760 | $0.623 | $0.700 | 12 636 |
| 2023-01-06 | $0.543 | $0.598 | $0.543 | $0.591 | 6 100 |
| 2023-01-05 | $0.517 | $0.600 | $0.515 | $0.515 | 12 222 |
| 2023-01-04 | $0.540 | $0.540 | $0.515 | $0.515 | 7 108 |
| 2023-01-03 | $0.484 | $0.510 | $0.484 | $0.500 | 4 974 |
| 2022-12-30 | $0.470 | $0.523 | $0.460 | $0.493 | 20 783 |
| 2022-12-29 | $0.542 | $0.577 | $0.470 | $0.508 | 41 275 |
| 2022-12-28 | $0.559 | $0.570 | $0.559 | $0.560 | 7 818 |
| 2022-12-27 | $0.590 | $0.620 | $0.560 | $0.580 | 6 329 |
| 2022-12-23 | $0.616 | $0.635 | $0.570 | $0.635 | 10 565 |
| 2022-12-22 | $0.610 | $0.675 | $0.560 | $0.645 | 31 903 |
| 2022-12-21 | $0.750 | $0.760 | $0.604 | $0.722 | 153 587 |
| 2022-12-20 | $1.01 | $1.05 | $1.01 | $1.05 | 6 987 |
| 2022-12-19 | $0.99 | $1.02 | $0.99 | $1.02 | 400 |
| 2022-12-16 | $1.07 | $1.07 | $0.97 | $0.99 | 2 820 |
| 2022-12-15 | $1.06 | $1.06 | $0.97 | $1.03 | 3 589 |
| 2022-12-14 | $0.99 | $1.00 | $0.99 | $0.99 | 3 828 |
| 2022-12-13 | $0.99 | $1.01 | $0.95 | $0.95 | 5 373 |
| 2022-12-12 | $1.02 | $1.05 | $1.02 | $1.05 | 336 |
| 2022-12-09 | $0.98 | $1.04 | $0.98 | $1.04 | 1 679 |
| 2022-12-08 | $0.98 | $1.03 | $0.98 | $1.03 | 328 |
| 2022-12-07 | $0.99 | $1.03 | $0.99 | $1.03 | 5 619 |
| 2022-12-06 | $0.99 | $1.03 | $0.99 | $1.00 | 7 607 |
| 2022-12-05 | $1.00 | $1.04 | $0.99 | $1.00 | 10 271 |
| 2022-12-02 | $1.00 | $1.04 | $0.99 | $1.01 | 4 638 |
| 2022-12-01 | $1.00 | $1.00 | $0.98 | $0.99 | 5 213 |
| 2022-11-30 | $1.02 | $1.03 | $0.97 | $1.00 | 5 862 |
| 2022-11-29 | $1.01 | $1.06 | $1.01 | $1.06 | 2 416 |
| 2022-11-28 | $1.08 | $1.08 | $1.03 | $1.06 | 1 986 |
| 2022-11-25 | $1.03 | $1.10 | $1.03 | $1.07 | 9 084 |
| 2022-11-23 | $1.03 | $1.05 | $1.02 | $1.02 | 1 950 |
| 2022-11-22 | $1.10 | $1.16 | $1.03 | $1.08 | 14 853 |
About Celyad SA
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical... CYAD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
